InforSense and Elsevier MDL Expand Strategic Relationship
InforSense joins the MDL® Isentris® Alliance
London, UK, Cambridge, MA, USA, and San Leandro, CA, USA — October 11, 2005 — InforSense and Elsevier MDL today announced an expanded strategic relationship to integrate the new-generation MDL® Isentris® informatics platform and the InforSense KDE workflow-based integrative analytics platform, and to explore further joint development initiatives. The collaboration will enable scientists in the life sciences to use information and knowledge more effectively in decision-making in order to enhance R&D productivity.
“For life scientists, informatics tools that work together offer clear promise for improving R&D productivity,” said Lars Barfod, CEO of Elsevier MDL. “Through our expanded partnership under the MDL Isentris Alliance, InforSense and Elsevier MDL will provide mutual customers with built-in compatibility between the powerful Isentris informatics foundation and the dynamic InforSense KDE integrative analytics platform. This interoperability between essential technologies gives scientists the tools to make successful research decisions more efficiently.”
“Jointly, InforSense and Elsevier MDL can provide research organizations with a more comprehensive application development environment,” said Joseph F. Donahue, Chief Business Officer of InforSense. “The combination of technologies provides researchers with enhanced ability to compose, optimize and deliver applications across life sciences R&D to achieve their productivity goals. We will also be exploring additional developments to leverage both companies’ complementary integrative analytics and workflow expertise.”
Elsevier MDL has been a member of the InforSense Open Workflow Partner Network (OWPN) since March 2005, and mutual customers already benefit from the integration of MDL chemistry applications (including MDL® Direct data cartridges and MDL® ISIS/Draw) with both InforSense KDE and its ‘in Oracle’ enterprise analytics system, InforSense Oracle Edition. Under the new agreement, InforSense becomes a preferred member of the MDL® Isentris® Alliance, a growing community of companies joining forces to improve the value of offerings from different vendors by utilizing an open technology framework optimized for scientific applications.
Within the expanded partnership, the companies will work together to provide support for and connectivity between the MDL Isentris product family, including MDL Draw, and the InforSense KDE integrative analytics framework. The companies will also explore other areas of technical collaboration.
About Elsevier MDL
Elsevier MDL provides informatics, database and workflow solutions that accelerate successful life sciences R&D by improving the speed and quality of scientists’ decision making. Researchers around the world depend on Elsevier MDL for innovative and reliable discovery informatics software solutions and services augmented by 400 Elsevier chemistry and life sciences journals and related products. For more information, visit www.mdl.com. Elsevier is a world-leading publisher of scientific, technical and medical information products and services.
Elsevier is part of Reed Elsevier Group plc, a world-leading publisher and information provider. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange). For more information, visit www.reedelsevier.com.
About MDL Isentris
MDL Isentris is the first complete, out-of-the-box, n-tier informatics architecture supporting enterprise-wide business process, data and application integration for the life sciences. Isentris streamlines the storage, integration and retrieval of a broad range of chemistry and biology data, enabling scientists to access the right information at the right time, in the right context and format.
InforSense Limited, the leader in integrative analytics, enables organizations to orchestrate and optimize their business-critical decision-making processes. Leading pharmaceutical and biotechnology companies, financial services companies, and research institutes are using the company’s flagship product, InforSense KDE, to enhance productivity across life science R&D, healthcare and business analytics. The company is privately held, with European headquarters in London, UK and North American headquarters in Cambridge, Massachusetts.
About InforSense KDE
Using InforSense KDE, enterprises rapidly integrate and deliver virtually any data source, analytic software tool, service or application within a single informatics framework. Users link these components via visual workflows to dynamically answer any question using their data, however complex or transient. Organizations can also mine their analytical processes to discover and deploy expertise and best practises. InforSense KDE provides an open, extensible service-oriented architecture, built using industry standards including J2EE, XML, and WSDL. The InforSense Oracle Edition is a state-of-the-art solution for enterprise wide integrative analytics using Oracle’s advanced information management and processing capabilities. For further information on InforSense products and solutions, visit www.inforsense.com.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Dr. Judith Bandy
Director of Corporate Communications
+44 (20) 7808 9500
Dr. Phil McHale
VP, Market and Corporate Communications
(510) 357-2222 ext. 3541
InforSense and the InforSense logo are registered trademarks of InforSense Limited. All rights reserved. MDL and Isentris are registered trademarks of MDL Information Systems, Inc. (‘Elsevier MDL’) in the United States. All rights reserved. All other trademarks mentioned in this document are the property of their respective owners.